XTBD1 and neoplasm: This study aimed to comprehensively analyze <i>CDKN2AIPNL's</i> expression patterns, prognostic value, genetic alterations, and molecular mechanisms across multiple tumor types using public datasets including TCGA, GTEx, HPA, and tools such as GEPIA2, cBioPortal, TIMER2, STRING, and BioGRID.